查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467888

2024-2032 年女性健康诊断市场报告（按类型、应用、最终用户和地区）

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球女性健康诊断市场规模达到292亿美元。

女性健康诊断有助于诊断女性患者的各种生物和社会心理状况。它们有助于解决性和阴道问题以及怀孕併发症，并控制威胁疾病，例如骨质疏鬆症、更年期以及某些癌症（如乳癌和子宫颈癌）。他们依赖一系列先进的实验室测试、工具和程序，包括活检、超音波、化疗和磁振造影 (MRI)。一些医疗保健诊断中心目前正在提供广泛的实验室检测解决方案，以加强对影响女性的罕见疾病和病症的诊断和管理。

女性健康诊断市场趋势：

影响女性整体福祉的健康问题日益普遍，是对市场产生正面影响的主要因素之一。此外，健康意识的增强以及对早期诊断益处的认识不断增强，正在推动全球对即时护理 (POC) 女性健康诊断的需求。除此之外，由于生活方式的压力以及酒精和毒品消费的增加，不孕率不断上升，这推动了对妇女健康诊断的需求，以解决妊娠併发症并确保更健康的生活。此外，由于更年期会增加某些疾病的风险，包括心血管疾病和尿失禁，因此50岁以上女性人口的显着增加也促进了市场的成长。除此之外，多项研究得出的结论是，女性在荷尔蒙变化期间更容易出现精神疾病，例如忧郁和焦虑。这与许多国家的卫生机构为改善妇女心理健康而采取的多项措施相结合，正在推动全球市场的成长。

本报告回答的关键问题

  • 2023年全球女性健康诊断市场规模有多大？
  • 2024-2032年全球女性健康诊断市场的预期成长率是多少？
  • 推动全球女性健康诊断市场的关键因素是什么？
  • COVID-19 对全球女性健康诊断市场有何影响？
  • 全球女性健康诊断市场按类型划分是怎样的？
  • 基于应用的全球女性健康诊断市场的细分如何？
  • 基于最终用户的全球女性健康诊断市场的细分情况如何？
  • 全球女性健康诊断市场的重点区域有哪些？
  • 全球女性健康诊断市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球女性健康诊断市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 诊断设备
    • 市场走向
    • 关键环节
      • 切片装置
      • 影像和监测设备
      • 配件及消耗品
    • 市场预测
  • 诊断测试
    • 市场走向
    • 关键环节
      • 乳癌检测
      • 子宫颈抹片检查和 HPV 检测
      • 怀孕测试和排卵测试
      • 其他的
    • 市场预测

第 7 章：市场区隔：按应用

  • 乳癌
    • 市场走向
    • 市场预测
  • 传染病检测
    • 市场走向
    • 市场预测
  • 骨质疏鬆症测试
    • 市场走向
    • 市场预测
  • 怀孕和生育力测试
    • 市场走向
    • 市场预测
  • 性传染病检测
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院和诊断中心
    • 市场走向
    • 市场预测
  • 居家护理
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Cardinal Health Inc.
    • Cook Group Incorporated
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • Hologic Inc.
    • Koninklijke Philips NV
    • Perkinelmer Inc.
    • Quest Diagnostics Inc.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A4956

The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.

Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.

Women's Health Diagnostics Market Trends:

The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women's health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women's health diagnostics to address pregnancy complications and ensure a healthier life. Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global women's health diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application, and end user.

Breakup by Type:

Diagnostic Devices

Biopsy Device

Imaging and Monitoring Devices

Accessories and Consumables

Diagnostic Tests

Breast Cancer Testing

PAP Smear and HPV Test

Pregnancy Testing and Ovulation Testing

Others

Breakup by Application:

Breast Cancer

Infectious Disease Testing

Osteoporosis Testing

Pregnancy and Fertility Testing

Sexually Transmitted Disease Testing

Others

Breakup by End User:

Hospital and Diagnostics Centers

Home Care

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global women's health diagnostics market in 2023?
  • 2. What is the expected growth rate of the global women's health diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global women's health diagnostics market?
  • 4. What has been the impact of COVID-19 on the global women's health diagnostics market?
  • 5. What is the breakup of the global women's health diagnostics market based on the type?
  • 6. What is the breakup of the global women's health diagnostics market based on the application?
  • 7. What is the breakup of the global women's health diagnostics market based on the end user?
  • 8. What are the key regions in the global women's health diagnostics market?
  • 9. Who are the key players/companies in the global women's health diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Women's Health Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostic Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Biopsy Device
      • 6.1.2.2 Imaging and Monitoring Devices
      • 6.1.2.3 Accessories and Consumables
    • 6.1.3 Market Forecast
  • 6.2 Diagnostic Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Breast Cancer Testing
      • 6.2.2.2 PAP Smear and HPV Test
      • 6.2.2.3 Pregnancy Testing and Ovulation Testing
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Breast Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Disease Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Osteoporosis Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pregnancy and Fertility Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Sexually Transmitted Disease Testing
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Care
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cardinal Health Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cook Group Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 General Electric Company
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Hologic Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Perkinelmer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Quest Diagnostics Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Siemens AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
  • Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
  • Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
  • Table 7: Global: Women's Health Diagnostics Market: Key Players